HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO ., LTD .

Business Type:Manufacturer

Main Products:heparin sodium,enoxaparin sodium,dalteparin sodium,nadroparin calcium,sodium hyaluronate,heparin sodium injection,enoxaparin sodium injection,dalteparin sodium injection,nadroparin calcium injection

Country/Region:China

Annual Revenue:300000000 RMB

Main Markets:South America,Eastern Europe,Southeast Asia,Africa,Western Europe,

Ddu Verified

HOT Rank

6/10
Company Information

Hebei Changshan Biochemical Pharmaceutical Co., Ltd., abbreviated as “Changshan Pharma”(stock code:300255) was established on Sept., 28th, 2000, is a unique heparin manufacturing company with full intergraded industrial chain in China . Our heparin products are sold to many countries in the world such as USA, France, Germany, Italy, Spain, Russia, India, and Japan.

In 2009,Changshan Pharma was approved as innovation enterprise by ministry of science and technology of China . In 2012, Changshan Pharma has established a unique national glycobiology research center . Our small volume injection, tablet, and solid capsule centers have been approved by SFDA as GMP facilities. Our API (Heparin Sodium, Enoxaparin Sodium, Nadroparin Calcium, Dalteparin Sodium) facility has been approved by SFDA, European CEP, France GMP, Japan PMDA, Germany GMP, and US FDA agencies.


Email to this supplier
To

Send

Inquiry Cart(0)